Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Expert Review of Clinical Immunology|December 15, 2016
DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasisPaul YamauchiClinics in Dermatology|May 26, 2004
Cosmetic uses of botulinum toxins for lower aspects of the face and neckNicholas J Lowe, Paul YamauchiJournal of Drugs in Dermatology : JDD|April 7, 2023
Drugs in Development for Chronic Spontaneous UrticariaWilliam Nguyen, Weiwei Liu, Paul YamauchiJournal of the American Academy of Dermatology|November 27, 2002
Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow's feetNicholas J Lowe, Gary Lask, Paul Yamauchi, et al.Lasers in Surgery and Medicine|July 17, 2003
Can patients treat themselves with a small novel light based hair removal system?Thomas E Rohrer, Vandana Chatrath, Paul Yamauchi, et al.Journal of Drugs in Dermatology : JDD|April 10, 2020
Halobetasol Propionate 0.01%/Tazarotene 0.045% Lotion for Moderate-to-Severe Psoriasis: Pooled Phase 3 Analysis of Lower ExtremitiesStephen Tyring, Leon H Kircik, Paul Yamauchi, et al.Advances in Therapy|March 22, 2024
'Totality of Evidence' Approach in the Development of GP2017, an Approved Adalimumab BiosimilarNorman Gaylis, Charlotte Both, Lena Lemke, et al.The Journal of Clinical and Aesthetic Dermatology|December 19, 2025
Impact of Oral DFD-29, a Low-Dose Formulation of Minocycline, on Quality of Life in Patients with Rosacea: Results of Two Phase 3 Randomized Controlled TrialsLinda Stein Gold, Paul Yamauchi, Thomas Dirschka, et al.Journal of Drugs in Dermatology : JDD|August 10, 2022
Treatment of Scalp PsoriasisRabia Ghafoor, Anant Patil, Paul Yamauchi, et al.Journal of Drugs in Dermatology : JDD|August 10, 2022
New Biologics and Oral Drugs in Treatment of Moderate to Severe PsoriasisHemalatha Naidu, Priyanka Karagaiah, Anant Patil, et al.Pageof 3